389 related articles for article (PubMed ID: 22660811)
1. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
2. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
4. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
[TBL] [Abstract][Full Text] [Related]
5. Self-reported fractures and associated factors in women with systemic lupus erythematosus.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Ramsey-Goldman R
J Rheumatol; 2007 Oct; 34(10):2018-23. PubMed ID: 17787041
[TBL] [Abstract][Full Text] [Related]
6. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
8. Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation study.
Leslie WD; Lix LM;
J Bone Miner Res; 2010 Feb; 25(2):388-92. PubMed ID: 19653809
[TBL] [Abstract][Full Text] [Related]
9. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
Mok CC; Wong SN; Ma KM
Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.
Rhew EY; Lee C; Eksarko P; Dyer AR; Tily H; Spies S; Pope RM; Ramsey-Goldman R
J Rheumatol; 2008 Feb; 35(2):230-6. PubMed ID: 18203323
[TBL] [Abstract][Full Text] [Related]
11. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
12. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
[TBL] [Abstract][Full Text] [Related]
13. [BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS--OUR RESULTS].
Gracanin AG; Marković I; Loncarević J; Golob M; Morović-Vergles J
Reumatizam; 2015; 62(2):16-21. PubMed ID: 26882799
[TBL] [Abstract][Full Text] [Related]
14. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data.
Ramsey-Goldman R; Dunn JE; Huang CF; Dunlop D; Rairie JE; Fitzgerald S; Manzi S
Arthritis Rheum; 1999 May; 42(5):882-90. PubMed ID: 10323443
[TBL] [Abstract][Full Text] [Related]
15. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
Leslie WD; Lix LM;
J Bone Miner Res; 2011 Mar; 26(3):460-7. PubMed ID: 20839285
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
19. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
Dhanapal V; Reeves DJ
J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
[TBL] [Abstract][Full Text] [Related]
20. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
Watts NB
J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
